New Weight Loss Drug May Launch in US After Promising Clinical Trial
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 3, 2023
Pharmaceutical giant Eli Lilly said Thursday it will seek approval to add its diabetes drug to the buzzy US weight loss market after achieving promising results in a new clinical trial. Tirzepatide, currently approved to treat type 2 diabetes under the name Mounjaro, is taken once a week as an injection.
Let's personalize your content